9rules - The best content from the independent web.

Browse 9rules By - Great blogs sorted by topic at 9rules.

Pharma Strategy Blog By Sally Church

Member Since 2009 of the Science Community

Recent Posts

Exciting times in CLL: an ASCO 2013 interview with Dr Susan O’Brien »

Posted Jun 10, 2013

Comment on ASCO 2013 Highlights Part 2 by maverickny »

Posted May 29, 2013

Comment on ASCO 2013 Highlights Part 2 by Haberman Associates »

Posted May 29, 2013

ASCO 2013 Highlights Part 2 »

Posted May 28, 2013

Comment on ASCO 2013 Highlights PD-1 and PD-L1 immunotherapy by maverickny »

Posted May 28, 2013

Comment on ASCO 2013 Highlights PD-1 and PD-L1 immunotherapy by Juan P. Serrate, DVM »

Posted May 28, 2013

ASCO 2013 Highlights PD-1 and PD-L1 immunotherapy »

Posted May 16, 2013

Reflections of a Medical Oncologist on AACR 2013 »

Posted Apr 22, 2013

Overcoming drug resistance in lung cancer »

Posted Apr 17, 2013

Comment on Overcoming resistance to vemurafenib in metastatic melanoma by maverickny »

Posted Apr 17, 2013

Overcoming resistance to vemurafenib in metastatic melanoma »

Posted Apr 15, 2013

AACR 2013 – some initial thoughts on the emerging trends »

Posted Apr 11, 2013

Palifosfamide – a predictable miss in soft tissue sarcoma? »

Posted Mar 26, 2013

Help make colonoscopies more affordable as an effective screening tool »

Posted Mar 20, 2013

Bromodomain Inhibitors – an exciting new target in cancer research? »

Posted Mar 11, 2013

ASH 2012 update on ARRY-520 in multiple myeloma »

Posted Mar 01, 2013

Will biomarkers revolutionalise treatment with tivozanib? »

Posted Feb 25, 2013

ASCO GU update on tivozanib in advanced clear cell renal cancer »

Posted Feb 21, 2013

Tumor Lysis Syndrome – what is it and why is it important in cancer research? »

Posted Feb 18, 2013

Making a difference in Advanced Prostate Cancer – an interview with Bertrand Tombal »

Posted Feb 15, 2013